The FDA has named Dexcom as the first medical device manufacturer that will take part in a pilot programme that could make it ...

Armed with new pivotal trial results, Eli Lilly plans to file for approval of its keenly anticipated new weight-loss therapy, ...

The EU has delivered some good news to AstraZeneca's oncology business, approving its oral selective oestrogen receptor degrader (SERD) for breast cancer, even as it faces obstacles on its path to ...

GSK has won FDA approval for Jideytro, a drug at the heart of its $10.6 billion acquisition of Nuvalent earlier this year – ...

After a delay of several years, people living with multiple sclerosis in England will finally be able to get NHS access to ...

China has become the first country to approve Takeda's first-in-class orexin agonist, oveporexton, for the sleep disorder ...

The intense rivalry between Novo Nordisk and Eli Lilly in the market for GLP-1 agonist-based therapies for obesity and type 2 ...

In the first big announcement from this year's JPM Healthcare conference, AbbVie has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug ...

Reports are emerging that a multibillion-dollar partnership between AbbVie and Alphabet-backed biotech Calico has come to an end after more than a decade. The divorce – first report by Stat – comes ...

Eisai and Biogen have won FDA approval for a subcutaneous injection version of Leqembi that could help accelerate uptake of the Alzheimer's disease therapy. The green light for Leqembi Iqlik ...

Eli Lilly has stepped up its campaign to encourage people to use its weight-loss drug Zepbound over copycat drugs from other sources, such as compounding pharmacies. The drugmaker used a 30-second ...

Basecamp Research has launched a new scientific initiative, called the Trillion Gene Atlas, to bring together genomic data from millions of species and use it to guide and scale AI-powered design of ...